Published in Health Business Week, October 15th, 2004
As of August 31, 2004, the company had repurchased 1,477,000 shares. Timing of repurchases and exact number of shares of common stock to be purchased in the future will depend upon prevailing market conditions and other factors.
Federico Pignatelli, Biolase's chairman commented, "We believe that our shares continue to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.